Pelthos Therapeutics (PTHS) Current Leases (2025 - 2026)

Pelthos Therapeutics (PTHS) posted quarterly Current Leases of $635000.0 for Q4 2025, up 0.63% quarter-over-quarter from $631000.0 in Q3 2025.

Pelthos Therapeutics (PTHS) Current Leases (2025 - 2026) Analysis & Trends

Pelthos Therapeutics' Current Leases history runs 1 years deep, the most recent figure standing at $635000.0 for Q4 2025.

In Q4 2025, Current Leases changed N/A year-over-year to $635000.0; the TTM figure through Dec 2025 stood at $635000.0 (changed N/A YoY), while the FY2025 annual figure was $635000.0, changed N/A from the prior year.
Current Leases for Q4 2025 stood at $635000.0, up from $631000.0 in the prior quarter.
The five-year high for Current Leases was $635000.0 in Q4 2025, with the low at $631000.0 in Q3 2025.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Current Leases (Qtr)
1	Vertex Pharmaceuticals	139.40 Bn	131.54 Bn	2.84 Bn	-
2	Regeneron Pharmaceuticals	86.13 Bn	78.13 Bn	3.93 Bn	720.00 Mn
3	Argenx Se	65.58 Bn	60.40 Bn	1.37 Bn	-
4	Moderna	58.23 Bn	53.09 Bn	52.00 Mn	-
5	BeOne Medicines	42.18 Bn	37.08 Bn	1.53 Bn	21.95 Mn
6	Alnylam Pharmaceuticals	31.61 Bn	28.30 Bn	992.69 Mn	45.93 Mn
7	BioNTech SE	27.97 Bn	9.58 Bn	668.28 Mn	-
8	Insmed	27.55 Bn	26.39 Bn	358.27 Mn	6.27 Mn
9	Royalty Pharma	27.31 Bn	26.47 Bn	-	-
10	Pelthos Therapeutics	93.05 Mn	68.49 Mn	21.23 Mn	645,000.00

Download Data